USANA Health Sciences, Inc.
USNA
$33.82
$0.8552.59%
| Weiss Ratings | USNA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | C- | |||
| Rating Factors | USNA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | USNA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.01 | |||
| Price History | USNA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 18.07% | |||
| 30-Day Total Return | -1.53% | |||
| 60-Day Total Return | -11.39% | |||
| 90-Day Total Return | -8.14% | |||
| Year to Date Total Return | -7.08% | |||
| 1-Year Total Return | -30.39% | |||
| 2-Year Total Return | -43.69% | |||
| 3-Year Total Return | -61.19% | |||
| 5-Year Total Return | -50.69% | |||
| 52-Week High % Change | -34.50% | |||
| 52-Week Low % Change | 18.95% | |||
| Price | USNA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $50.32 | |||
| 52-Week Low Price | $27.71 | |||
| 52-Week Low Price (Date) | Feb 27, 2025 | |||
| 52-Week High Price (Date) | Mar 15, 2024 | |||
| Valuation | USNA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 628.20M | |||
| Enterprise Value | 523.66M | |||
| Price/Earnings (TTM) | 11.66 | |||
| Earnings Per Share (TTM) | 2.83 | |||
| Earnings Per Share Growth | -8.50% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.73 | |||
| Price/Book (Q) | 1.18 | |||
| Enterprise Value/Revenue (TTM) | 0.61 | |||
| Price | $33.82 | |||
| Enterprise Value/EBITDA (TTM) | 5.47 | |||
| Enterprise Value/EBIT | 6.36 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | USNA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 19.08M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | USNA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 801 954 7100 | |||
| Address | 3838 West Parkway Boulevard Salt Lake City, UT 84120 | |||
| Website | www.usana.com | |||
| Country | United States | |||
| Year Founded | 1992 | |||
| Profitability | USNA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 9.55% | |||
| Profit Margin | 6.30% | |||
| Management Effectiveness | USNA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.09% | |||
| Return on Equity | 10.83% | |||
| Income Statement | USNA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 861.97M | |||
| Total Revenue (TTM) | 861.97M | |||
| Revenue Per Share | $45.17 | |||
| Gross Profit (TTM) | 697.00M | |||
| EBITDA (TTM) | 95.79M | |||
| EBIT (TTM) | 82.33M | |||
| Net Income (TTM) | 54.34M | |||
| Net Income Avl. to Common (TTM) | 54.34M | |||
| Total Revenue Growth (Q YOY) | -6.16% | |||
| Earnings Growth (Q YOY) | -6.52% | |||
| EPS Diluted (TTM) | 2.83 | |||
| EPS Diluted Growth (Q YOY) | -5.70% | |||
| Balance Sheet | USNA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 364.89M | |||
| Cash Per Share (Q) | $19.12 | |||
| Total Current Assets (Q) | 451.19M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 533.09M | |||
| Current Ratio (Q) | 3.931 | |||
| Book Value Per Share (Q) | $27.97 | |||
| Total Assets (Q) | 671.31M | |||
| Total Current Liabilities (Q) | 114.78M | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 138.22M | |||
| Total Common Equity (Q) | 533.09M | |||
| Cash Flow | USNA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -15.27M | |||
| Cash from Financing (TTM) | -12.72M | |||
| Net Change in Cash (TTM) | 57.92M | |||
| Levered Free Cash Flow (TTM) | 63.87M | |||
| Cash from Operations (TTM) | 81.23M | |||
